Zydus Life gets tentative USFDA approval for tablets used to treat irritable bowel syndrome
Post Content
Latest News
Morgan Stanley sees three more OPEC+ hikes driving brent lower
Post Content
Apollo Hospitals is doubling down on its biggest and most profitable unit
Post Content
Dr Reddy’s, OneSource shares decline up to 3% after Delhi HC bans Semaglutide sales in India
Post Content
Nykaa shares fall after HSBC downgrade but bulls cite margin improvement
Post Content
Niva Bupa stock falls 11% after shares worth ₹391 crore change hands
Post Content
Top stock picks | Buy Bank of India, Glenmark & sell Asian Paints, NTPC
Post Content
AstraZeneca Pharma India shares rise 8% after revenue, margin jump in Q4
Post Content
May Auto Sales: Maruti Suzuki shares under pressure after passengers vehicles sales dip in May
Post Content
Weak debut: Leela Hotels shares list at a discount to IPO price
Post Content